Novo Nordisk A/S Message Board

Arena will be a major "cash cow" for years.

Obesity is growing worldwide.

Only a fool would sell now.

Sanofi could get it approved by the E.M.A.

Back to the most recent high of $11.05 by Friday is realistic.

Higher on D.E.A. news and a Belviq launch.

It would be very easy for Eisai to have another Japanese company make a lower offer to allow Eisai to then come in with a higher offer.

They'll be plenty available at $35.00.

Shorts are toast.

Dendreon went to $55.00.

It was impressive at the time.

I recall Cramer was saying to sell just before the run-up occurred.

He cost a lot of individuals 1,000% profits.

First revenue report from the company's Tarantula site in Arizona is due out at any time.

The company's C.E.O. was a director at the U.S. Mint in his previous position.

Visit the company's website to view pictures/video of the production process.

E.U. Approval??? $50.00????